This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Trio Medicines Ltd.
Drug Names(s): netazepide, FE-999008, YF476
Description: YF-476 is benzodiazepine type, selective cholecystokinin B receptor (gastrin receptor) antagonist with potential gastric acid reducing and antiproliferative activity that selectively binds to and blocks the CCKBR, thereby preventing the binding of gastrin and cholecystokinin.
Partners: Ferring BV
Additional information available to subscribers only: